Logo image of PACI

PROOF ACQUISITION CORP I-A (PACI) Stock Fundamental Analysis

NYSE:PACI - New York Stock Exchange, Inc. - US74349W1045 - Common Stock - Currency: USD

14.5  -5.5 (-27.5%)

After market: 16 +1.5 (+10.34%)

Fundamental Rating

2

PACI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. PACI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PACI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PACI had positive earnings in the past year.
In the past year PACI has reported a negative cash flow from operations.
PACI Yearly Net Income VS EBIT VS OCF VS FCFPACI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 1M -1M

1.2 Ratios

Industry RankSector Rank
ROA 7.91%
ROE 8.45%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PACI Yearly ROA, ROE, ROICPACI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 0.2 -0.2 0.4 -0.4

1.3 Margins

PACI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PACI Yearly Profit, Operating, Gross MarginsPACI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, PACI has about the same amount of shares outstanding.
PACI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PACI Yearly Shares OutstandingPACI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M
PACI Yearly Total Debt VS Total AssetsPACI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

PACI has an Altman-Z score of 25.64. This indicates that PACI is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for PACI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.64
ROIC/WACCN/A
WACCN/A
PACI Yearly LT Debt VS Equity VS FCFPACI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M 200M 250M

2.3 Liquidity

PACI has a Current Ratio of 0.52. This is a bad value and indicates that PACI is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.52 indicates that PACI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
PACI Yearly Current Assets VS Current LiabilitesPACI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 524.68% over the past year.
EPS 1Y (TTM)524.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 85.29 indicates a quite expensive valuation of PACI.
The average S&P500 Price/Earnings ratio is at 26.31. PACI is valued rather expensively when compared to this.
Industry RankSector Rank
PE 85.29
Fwd PE N/A
PACI Price Earnings VS Forward Price EarningsPACI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PACI Per share dataPACI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PACI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PROOF ACQUISITION CORP I-A

NYSE:PACI (12/1/2023, 8:15:11 PM)

After market: 16 +1.5 (+10.34%)

14.5

-5.5 (-27.5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.41%
Inst Owner Change-98.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap193.43M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 85.29
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.91
P/tB 2.91
EV/EBITDA N/A
EPS(TTM)0.17
EY1.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0
BVpS4.98
TBVpS4.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.91%
ROE 8.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 25.64
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)524.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.64%
OCF growth 3YN/A
OCF growth 5YN/A